Frequently asked questions

myTomorrows aims to break barriers for eligible patients seeking information about clinical trials and support referrals to trial sites. When patients are not eligible to clinical studies, we can help them and their physicians to navigate the complexities of expanded access programs.

Our digital platform connects all stakeholders in pre-approval access and supports both clinical trial and expanded access operations.

To support patients and their healthcare professionals discover and access all possible treatment options, myTomorrows developed the go-to platform for searching and accessing clinical trials and expanded access programs.

For patients & physicians, this includes time-saving tools and Patient Navigator support to search and identify clinical trials and expanded access programs, as well as a GDPR-compliant, ISO-27001 certified platform to upload and share medical information.

For trial sites, we provide high-quality patient referrals thanks to our pre-screening process. If requested and consented to by the patient, they will have access to the patient’s medical information, and if deemed potentially eligible, trial sites can directly get in touch with the patient to invite them to be screened further.

For BioPharma companies, we can offer visibility into their full patient recruitment funnel, from trial awareness to referral and outcomes of on-site screening visits. These insights help identify bottlenecks that can be addressed together.

In an expanded access setting, our platform enables end-to-end EAP facilitation and management. Additionally, myTomorrows’ fit-for-purpose EDC can be tailored for specific use cases according to client needs.

Our platform is fundamentally patient-centric, and therefore our data sharing procedures are subject to patient consent when it relates to their pseudonymized data.

Our Patient Navigators are an essential point of contact for patients to understand and find clinical trials and if available, expanded access programs. 

They are a familiar contact for patients throughout their journey of choice; while they cannot give medical advice, Patient Navigators are trained to explain complex medical concepts to patients. We offer dependable, multilingual support to patients covering U.S. and European time zones. 

Learn more about our services to patients here.

If you have a problem or concern about any of the products that are shipped or distributed via myTomorrows, we would like to hear from you. Please send an email to quality@mytomorrows.com.

myTomorrows has a regulatory responsibility to monitor the safety of drugs prescribed through its programs. To report an adverse event or adverse drug reaction, please send an email to safety@mytomorrows.com.

You can visit our careers page. 

If there is no job opening, you can submit an open application.  

We are dedicated to removing practical barriers for patients and physicians. That’s why our services are always provided free of charge; they include:

• offering information about clinical trials and expanded access programs.
• supporting physicians with the expanded access application process worldwide.  

We charge BioPharma companies for our services, which include supporting clinical trial recruitment and managing international expanded access programs, logistics, quality management, distribution, and real-world data collection. 

For physicians and their patients, myTomorrows ensures free and agnostic access to information about all potential pre-approval options, regardless of our collaborations with BioPharma companies. 

The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.   

However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options. 

Clinical trials are research studies that evaluate drugs in development. When a new treatment/drug is being researched and developed, it must be tested extensively to evaluate the safety and effectiveness of the treatment on patients’ health. Clinical trials are an essential part of developing new drugs to treat patients. Watch our video to learn more

Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available.  These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients. 

myTomorrows is committed to data privacy and data protection for all our stakeholders and are continuously working on improving our processes and products to reflect this commitment.  

Our patient-centric approach means that respect for the users’ data privacy is of utmost importance to us. In practice, this means that we ensure transparent data processing by clearly communicating the purposes and legal basis for collecting patients’ data. We use clear and concise consent requests for each step that involves medical information. We practice data minimization, and only aim to collect the information necessary to support individuals in their journey. 

In addition, our platform ensures data security through encryption and access control to prevent unauthorized access and data breaches. Our platform and all our digital solutions are ISO 27001-certified. We have regular audits and assessments to monitor our compliance with GDPR standards and continually improve our data protection practices. 

Any user of our services may exercise their rights under GDPR at any point by contacting us at dataprotection@mytomorrows.com as indicated in our Privacy Statement.

Do you have a question around data privacy, data processing, or data protection? Please reach out to dataprotection@mytomorrows.com. 

If you lose your login and/or password, please go to the login page and click ‘forgot your password?’. An email with a link will be sent to your email address. If you still incur difficulties, please contact us via hello@mytomorrows.com.

myTomorrows operates globally and has offices in Amsterdam and New York City. Through these offices myTomorrows offers global coverage supported by our Program Management, Regulatory, Quality, Medical, Real-World Data, Pharmacovigilance and Supply/Logistics professionals.

A team of patient navigators provides global support to learn more about pre-approval options around the clock operating from the United States and Europe.